GTC Biotherapeutics (fka GTCB)

[Biowatch]

>>if “squeezing” were to hurt the prospective partner financially, it could backfire on the squeezer by lessening the productivity of the eventual partnership.<<

Yes, it's in everyone's best interest that the small company has sufficient funds to accomplish the goal efficiently and without incentive to cut corners. As long as reasonable oversight makes sure money isn't wasted (good idea regardless), short changing necessary work is like cutting off your nose to spite your face.